Global Human Prothrombin Complex Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

45834

Publisher Name

Global Info Research

Published Date

2/18/2019

No of Pages

116

Market Scenario

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. Scope of the Report: The global average price of Human Prothrombin Complex is in the increasing trend, from 124 USD/Unit in 2013 to 137 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years. The classification of Human Prothrombin Complex includes 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial and others, and the proportion of 500 IU/Vial in 2017 is about 51%. Human Prothrombin Complex is widely used in Hemophilia B, Vitamin K Deficiency and other diseases. The most proportion of Human Prothrombin Complex is Hemophilia B, and the proportion of sales is 48%. North America is the largest consumption place, with a consumption market share nearly 46% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 33%. Market competition is not intense. Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The worldwide market for Human Prothrombin Complex is expected to grow at a CAGR of roughly 11.8% over the next five years, will reach 1940 million US$ in 2024, from 1000 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Human Prothrombin Complex in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Shire CSL Grifols Octapharma Hualan Biological Meheco Xinxing Pharma Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers 500 IU/Vial 600 IU/Vial 1000 IU/Vial Others Market Segment by Applications, can be divided into Hemophilia B Vitamin K Deficiency Others The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Human Prothrombin Complex product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Human Prothrombin Complex, with price, sales, revenue and global market share of Human Prothrombin Complex in 2017 and 2018. Chapter 3, the Human Prothrombin Complex competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Human Prothrombin Complex breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Human Prothrombin Complex market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Human Prothrombin Complex sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 Human Prothrombin Complex Introduction 1.2 Market Analysis by Type 1.2.1 500 IU/Vial 1.2.2 600 IU/Vial 1.2.3 1000 IU/Vial 1.2.4 Others 1.3 Market Analysis by Applications 1.3.1 Hemophilia B 1.3.2 Vitamin K Deficiency 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Shire 2.1.1 Business Overview 2.1.2 Human Prothrombin Complex Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Shire Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 CSL 2.2.1 Business Overview 2.2.2 Human Prothrombin Complex Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 CSL Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Grifols 2.3.1 Business Overview 2.3.2 Human Prothrombin Complex Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Grifols Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Octapharma 2.4.1 Business Overview 2.4.2 Human Prothrombin Complex Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Octapharma Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Hualan Biological 2.5.1 Business Overview 2.5.2 Human Prothrombin Complex Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Meheco Xinxing Pharma 2.6.1 Business Overview 2.6.2 Human Prothrombin Complex Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Human Prothrombin Complex Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Human Prothrombin Complex Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Human Prothrombin Complex Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Human Prothrombin Complex Manufacturer Market Share in 2018 3.3.2 Top 6 Human Prothrombin Complex Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Human Prothrombin Complex Market Analysis by Regions 4.1 Global Human Prothrombin Complex Sales, Revenue and Market Share by Regions 4.1.1 Global Human Prothrombin Complex Sales and Market Share by Regions (2014-2019) 4.1.2 Global Human Prothrombin Complex Revenue and Market Share by Regions (2014-2019) 4.2 North America Human Prothrombin Complex Sales and Growth Rate (2014-2019) 4.3 Europe Human Prothrombin Complex Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Human Prothrombin Complex Sales and Growth Rate (2014-2019) 4.5 South America Human Prothrombin Complex Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Human Prothrombin Complex Sales and Growth Rate (2014-2019) 5 North America Human Prothrombin Complex by Country 5.1 North America Human Prothrombin Complex Sales, Revenue and Market Share by Country 5.1.1 North America Human Prothrombin Complex Sales and Market Share by Country (2014-2019) 5.1.2 North America Human Prothrombin Complex Revenue and Market Share by Country (2014-2019) 5.2 United States Human Prothrombin Complex Sales and Growth Rate (2014-2019) 5.3 Canada Human Prothrombin Complex Sales and Growth Rate (2014-2019) 5.4 Mexico Human Prothrombin Complex Sales and Growth Rate (2014-2019) 6 Europe Human Prothrombin Complex by Country 6.1 Europe Human Prothrombin Complex Sales, Revenue and Market Share by Country 6.1.1 Europe Human Prothrombin Complex Sales and Market Share by Country (2014-2019) 6.1.2 Europe Human Prothrombin Complex Revenue and Market Share by Country (2014-2019) 6.2 Germany Human Prothrombin Complex Sales and Growth Rate (2014-2019) 6.3 UK Human Prothrombin Complex Sales and Growth Rate (2014-2019) 6.4 France Human Prothrombin Complex Sales and Growth Rate (2014-2019) 6.5 Russia Human Prothrombin Complex Sales and Growth Rate (2014-2019) 6.6 Italy Human Prothrombin Complex Sales and Growth Rate (2014-2019) 7 Asia-Pacific Human Prothrombin Complex by Country 7.1 Asia-Pacific Human Prothrombin Complex Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Human Prothrombin Complex Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Human Prothrombin Complex Revenue and Market Share by Country (2014-2019) 7.2 China Human Prothrombin Complex Sales and Growth Rate (2014-2019) 7.3 Japan Human Prothrombin Complex Sales and Growth Rate (2014-2019) 7.4 Korea Human Prothrombin Complex Sales and Growth Rate (2014-2019) 7.5 India Human Prothrombin Complex Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Human Prothrombin Complex Sales and Growth Rate (2014-2019) 8 South America Human Prothrombin Complex by Country 8.1 South America Human Prothrombin Complex Sales, Revenue and Market Share by Country 8.1.1 South America Human Prothrombin Complex Sales and Market Share by Country (2014-2019) 8.1.2 South America Human Prothrombin Complex Revenue and Market Share by Country (2014-2019) 8.2 Brazil Human Prothrombin Complex Sales and Growth Rate (2014-2019) 8.3 Argentina Human Prothrombin Complex Sales and Growth Rate (2014-2019) 8.4 Colombia Human Prothrombin Complex Sales and Growth Rate (2014-2019) 9 Middle East and Africa Human Prothrombin Complex by Countries 9.1 Middle East and Africa Human Prothrombin Complex Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Human Prothrombin Complex Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Human Prothrombin Complex Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Human Prothrombin Complex Sales and Growth Rate (2014-2019) 9.3 Turkey Human Prothrombin Complex Sales and Growth Rate (2014-2019) 9.4 Egypt Human Prothrombin Complex Sales and Growth Rate (2014-2019) 9.5 Nigeria Human Prothrombin Complex Sales and Growth Rate (2014-2019) 9.6 South Africa Human Prothrombin Complex Sales and Growth Rate (2014-2019) 10 Global Human Prothrombin Complex Market Segment by Type 10.1 Global Human Prothrombin Complex Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Human Prothrombin Complex Sales and Market Share by Type (2014-2019) 10.1.2 Global Human Prothrombin Complex Revenue and Market Share by Type (2014-2019) 10.2 500 IU/Vial Sales Growth and Price 10.2.1 Global 500 IU/Vial Sales Growth (2014-2019) 10.2.2 Global 500 IU/Vial Price (2014-2019) 10.3 600 IU/Vial Sales Growth and Price 10.3.1 Global 600 IU/Vial Sales Growth (2014-2019) 10.3.2 Global 600 IU/Vial Price (2014-2019) 10.4 1000 IU/Vial Sales Growth and Price 10.4.1 Global 1000 IU/Vial Sales Growth (2014-2019) 10.4.2 Global 1000 IU/Vial Price (2014-2019) 10.5 Others Sales Growth and Price 10.5.1 Global Others Sales Growth (2014-2019) 10.5.2 Global Others Price (2014-2019) 11 Global Human Prothrombin Complex Market Segment by Application 11.1 Global Human Prothrombin Complex Sales Market Share by Application (2014-2019) 11.2 Hemophilia B Sales Growth (2014-2019) 11.3 Vitamin K Deficiency Sales Growth (2014-2019) 11.4 Others Sales Growth (2014-2019) 12 Human Prothrombin Complex Market Forecast (2019-2024) 12.1 Global Human Prothrombin Complex Sales, Revenue and Growth Rate (2019-2024) 12.2 Human Prothrombin Complex Market Forecast by Regions (2019-2024) 12.2.1 North America Human Prothrombin Complex Market Forecast (2019-2024) 12.2.2 Europe Human Prothrombin Complex Market Forecast (2019-2024) 12.2.3 Asia-Pacific Human Prothrombin Complex Market Forecast (2019-2024) 12.2.4 South America Human Prothrombin Complex Market Forecast (2019-2024) 12.2.5 Middle East and Africa Human Prothrombin Complex Market Forecast (2019-2024) 12.3 Human Prothrombin Complex Market Forecast by Type (2019-2024) 12.3.1 Global Human Prothrombin Complex Sales Forecast by Type (2019-2024) 12.3.2 Global Human Prothrombin Complex Market Share Forecast by Type (2019-2024) 12.4 Human Prothrombin Complex Market Forecast by Application (2019-2024) 12.4.1 Global Human Prothrombin Complex Sales Forecast by Application (2019-2024) 12.4.2 Global Human Prothrombin Complex Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now